BCTX BRIACELL THERAPEUTICS CORP Capital Structure Changes 8-K Filing 2024 - Public Offering Briacell Therapeutics Corp. completed a public offering of 7.4 million units at $0.75 each, raising approximately $5.55 million for working capital and business objectives, with warrants included for future share purchases.Get access to all SEC 8-K filings of the BRIACELL THERAPEUTICS CORP